tiprankstipranks
Trending News
More News >
AIM Vaccine Co., Ltd. Class H (HK:6660)
:6660
Hong Kong Market
Advertisement

AIM Vaccine Co., Ltd. Class H (6660) Revenue

Compare
2 Followers

AIM Vaccine Co., Ltd. Class H Revenue

AIM Vaccine Co., Ltd. Class H had a revenue of 747.85M in the quarter ending Dec 31, 2024, with 39.22%. This bring the company's revenue in the last twelve months to 1.29B, Decreased 8.52%. In the fiscal year ending Dec 31, 2024, AIM Vaccine Co., Ltd. Class H had annual revenue of 1.29B with 8.22% growth.
Revenue (ttm)
1.29B
Revenue Growth
6.48%
P/S Ratio
Revenue/Employee
HK$837,154
Employees
1,535
Market Cap

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
1.29B97.56M+108.22%
Dec 31, 2023
1.19B-76.61M+93.94%
Dec 31, 2022
1.26B-306.06M+80.51%
Dec 31, 2021
1.57B-67.84M+95.86%
Dec 31, 2020
1.64B686.32M+172.12%
Dec 31, 2019
951.65M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis